Literature DB >> 18371327

Is Ewing's sarcoma a stem cell tumor?

Paul S Meltzer1.   

Abstract

Solving the histogenesis of Ewing's sarcoma has defied investigators despite progress in understanding its molecular pathogenesis. In a recent issue of Cancer Cell, Tirode et al. (2007) present evidence supporting the hypothesis that this rare cancer arises from a primitive mesenchymal precursor.

Entities:  

Mesh：

Year:  2007        PMID： 18371327     DOI： 10.1016/j.stem.2007.05.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  17 in total

1.  BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma.

Authors:  J H Hsu; E R Lawlor
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

2.  Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence.

Authors:  Joonseok Cho; Hongmei Shen; Hui Yu; Hongjie Li; Tao Cheng; Sean Bong Lee; Byeong Chel Lee
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells.

Authors:  Xiaohua Jiang; Ynnez Gwye; Sonja J McKeown; Marianne Bronner-Fraser; Carolyn Lutzko; Elizabeth R Lawlor
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

4.  Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.

Authors:  Aaron Cooper; John van Doorninck; Lingyun Ji; Darren Russell; Marc Ladanyi; Hiroyuki Shimada; Mark Krailo; Richard B Womer; Jessie Hao-ru Hsu; Dafydd Thomas; Timothy J Triche; Richard Sposto; Elizabeth R Lawlor
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

Review 5.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

6.  Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.

Authors:  Haley L Peters; Ying Yan; Tara M Nordgren; Christine E Cutucache; Shantaram S Joshi; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2013-06-26       Impact factor: 4.742

7.  BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.

Authors:  Dorothea Douglas; Jessie Hao-Ru Hsu; Long Hung; Aaron Cooper; Diana Abdueva; John van Doorninck; Grace Peng; Hiro Shimada; Timothy J Triche; Elizabeth R Lawlor
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 8.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

Review 9.  The adolescent and young adult with cancer: state of the art -- bone tumors.

Authors:  Nino Rainusso; Lisa L Wang; Jason T Yustein
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 10.  Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?

Authors:  Elizabeth R Lawlor; Poul H Sorensen
Journal:  Crit Rev Oncog       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.